Safer syringe program aims to cut infections in drug users worldwide

NCT ID NCT06395129

First seen Nov 01, 2025

Summary

This study looks at whether giving out special syringes with less leftover space (low dead-space) can help reduce the spread of HIV and hepatitis among people who inject drugs. Researchers will talk with participants and track their health in several countries. The goal is to find the best way to run these programs and make them more acceptable and effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Hepa+

    RECRUITING

    Tbilisi, Georgia

    Contact Email: •••••@•••••

  • Mefada

    RECRUITING

    Kinondoni, Tanzania

    Contact Email: •••••@•••••

  • Mukikute

    RECRUITING

    Dar es Salaam, Tanzania

    Contact Email: •••••@•••••

  • New Vector

    RECRUITING

    Rustavi, Georgia

    Contact Email: •••••@•••••

  • Peer 2 Peer

    RECRUITING

    Dar es Salaam, Tanzania

    Contact Email: •••••@•••••

  • Real World Real People

    RECRUITING

    Yerevan, Armenia

    Contact Email: •••••@•••••

  • STEPS Tanzania

    RECRUITING

    Ubungo, Tanzania

    Contact Email: •••••@•••••

  • Step to Future

    RECRUITING

    Gori, Georgia

    Contact Email: •••••@•••••

  • Yovaribe

    RECRUITING

    Ilala, Tanzania

    Contact Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

AIDS Harm Reduction hepatitis HIV infectious disease substance abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.